Who owns Progenics Pharmaceuticals?

Key details on Progenics Pharmaceuticals (Ticker: PGNX)

Who owns Progenics Pharmaceuticals?

Is PGNX a good stock to own? Find out who bought Progenics Pharmaceuticals, who sold Progenics Pharmaceuticals (PGNX) stock, and who holds a large position in Progenics Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 13.51M $102.12M Dec. 31, 2014
Broadfin Capital 9.15M $69.18M Dec. 31, 2014
FMR 5.04M $26.18M Sept. 30, 2014
Baker Bros. Advisors 4.45M $33.64M Dec. 31, 2014
STATE STREET CORPORATION 3.16M $23.89M Dec. 31, 2014
BlackRock Fund Advisors 2.75M $20.75M Dec. 31, 2014
Tudor Investment Corporation 2.37M $17.92M Dec. 31, 2014
Vanguard 2.09M $15.82M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 2.07M $15.67M Dec. 31, 2014
Royce & Associates 1.68M $12.72M Dec. 31, 2014
Highland Capital Management 1.59M $8.25M Sept. 30, 2014
Wellington Management Company 1.45M $10.93M Dec. 31, 2014
Tiger Management 1.29M $9.74M Dec. 31, 2014
Oxford Asset Management 1.10M $8.36M Dec. 31, 2014
Phocas Financial 1.05M $7.92M Dec. 31, 2014
Deerfield Management Company 1.04M $5.60M March 31, 2013
NORTHERN TRUST 856489 $4.57M Dec. 31, 2013
MORGAN STANLEY 814948 $4.23M Sept. 30, 2014

Who sold Progenics Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perceptive Advisors Dec. 31, 2010 1.17M $6.38M